Atorvastatin Calcium Tablet
Product Images NDC 68071-2991

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2991 9)

Pdp (68071 2991 9)
Atorvastatin Calcium 40 mg tablets label from NuCare Pharmaceuticals, Inc., NDC 68071-2991-9. The label indicates a package of 90 film-coated oral tablets, each containing 40 mg Atorvastatin Calcium USP equivalent. Tablets are described as oval, white to off-white, with 'C3' imprint on one side. The label includes manufacturer and packaging information, dosage instructions, and storage conditions.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing cumulative incidence percentages over time in years, comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin, and the dashed line represents placebo, demonstrating lower cumulative incidence with Atorvastatin. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph comparing the cumulative hazard percentage over time between Atorvastatin and placebo groups, showing time to first primary endpoint through approximately 4 years of follow-up. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval and p-value, illustrating statistical comparison of outcomes.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph depicting the percentage of subjects experiencing a major cardiovascular event over time (in years), comparing Atorvastatin 10 mg and Atorvastatin 80 mg dosages. The x-axis shows time to first event up to 5 years, and the y-axis indicates the percentage of subjects. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval and p-value noted.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Atorvastatin Calcium, showing the molecular arrangement including calcium and water of hydration (3H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.